MedPath
NMPA Approval

Human Immunoglobulin

国药准字S20247006

July 5, 2024

国药准字S10980028

Drug Information

人免疫球蛋白

注射剂(注射液)

300mg/支(10%,3ml)

生物制品

July 5, 2024

Company Information

Applicant Company

成都高新区安泰五路888号

Manufacturing Company

成都高新区安泰五路888号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

人免疫球蛋白 - NMPA 批准文号 | MedPath